VRTX · Healthcare
Vertex Pharmaceuticals Inc
34/100
Smart-money confidence1 of 3 sources positive
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
45
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$132.8B
Industry
Biotechnology
Sector
Healthcare
Exchange
NasdaqGS
About VERTEX PHARMACEUTICALS INC
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of…
Who's behind the signal
Every informed buyer we can see on VRTX, across all three feeds.
Hedge funds · 8
D.E. Shaw & Co
New position
Tweedy Browne
Increased +3%
AQR Capital Management
Increased +19%
Citadel Advisors
Decreased −21%
Baillie Gifford & Co
Unchanged
Gotham Asset Mgmt (Greenblatt)
Decreased −3%
+2 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 9 on record
Disclosures from 2015-05-13 to 2022-03-29
The newest disclosure we hold for this stock is 2022-03-29.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2022-03-29 | William R. Keating · D-MA | House | Bought | $1,001 - $15,000 |
| 2021-01-28 | Peter Meijer · R-MI | House | Sold | $1,001 - $15,000 |
| 2020-12-18 | Dean Phillips · D-MN | House | Bought | $1,001 - $15,000 |
| 2020-11-19 | Kenny Marchant · R-TX | House | Sold | $1,001 - $15,000 |
| 2019-06-24 | Donna E. Shalala · D-FL | House | Sold | $1,001 - $15,000 |
| 2019-04-18 | Donna E. Shalala · D-FL | House | Bought | $1,001 - $15,000 |
| 2019-02-04 | Jack Reed · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2018-03-09 | Jack Reed · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2015-05-13 | Jack Reed · D-RI | Senate | Sold | $1,001 - $15,000 |
Not a model pick — but on our radar.
VERTEX PHARMACEUTICALS INC isn't in the top-10 model right now, but 8 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
8
Investors
1
New positions
2
Increasing
4
Decreasing
1
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.0×
% of portfolio
0.1%
Position change
NEW
0.1% of D.E. Shaw & Co's portfolio
Trust weight: 1.2×
% of portfolio
1.4%
Position change
+3%
1.4% of Tweedy Browne's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+19%
0.0% of AQR Capital Management's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
−21%
0.1% of Citadel Advisors's portfolio
Trust weight: 1.4×
% of portfolio
0.1%
Position change
—
0.1% of Baillie Gifford & Co's portfolio
Trust weight: 1.1×
% of portfolio
0.0%
Position change
−3%
0.0% of Gotham Asset Mgmt's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
−51%
0.0% of Bridgewater Associates's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−92%
0.0% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to VERTEX PHARMACEUTICALS INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell VERTEX PHARMACEUTICALS INC or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime